A Medical Device Daily
Misys Healthcare Systems (Raleigh, North Carolina), a healthcare IT developer, and iMedica (Santa Clara, California/Carollton, Texas), a developer of healthcare software for small physician practices, reported an agreement in which Misys will license iMedica’s electronic health record (EHR) and practice management (PM) solutions to build a family of physician offerings for small practices.
Initial products, including ASP service offerings, will complement Misys’s existing suite of solutions, including Misys Vision, Misys Tiger, Misys EMR and Misys Payerpath.
iMedica also will act as a reseller of Misys’ Payerpath revenue cycle and transaction management services to its customers.
Vern Davenport, executive VP and general manager of Misys, said, “iMedica’s technology delivers a time-to-market advantage that will enable us to quickly introduce compelling solutions under the Misys brand.”
iMedica CEO Michael Nissenbaum said, “The combination of iMedica’s technology and the deep market expertise Misys has established over 30 years will result in solutions at the forefront of innovation that provide immediate and long-term benefits to iMedica’s customers and prospects.”
In other agreement news:
• ARUP Laboratories (Salt Lake City), a clinical and anatomic pathology reference lab, reported renewal of a multi-source group purchasing agreement with Premier Purchasing Partners (Chicago), extending a contract between them, in effect since 1997, under which ARUP provided testing services to Premier’s clients within the U.S. The renewed contract runs from Oct. 1, 2007, through Sept. 30, 2010.
ARUP will continue to serve as an authorized provider of laboratory testing services for Premier’s alliance of more than 1,500 affiliate hospital and healthcare facilities.
Ronald Weiss, MD, president/COO of ARUP, said, “Our long-standing partnership further enables us to pursue our common goal of supporting our clients’ success and providing excellent patient care.”
ARUP, an enterprise of the University of Utah and its department of Pathology, offers more than 2,000 tests and test combinations, from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country.
• Ariba (Sunnyvale, California), a spend management solutions provider, reported an agreement with Biomet (Warsaw, Indiana), for Biomet to use Ariba’s Spend Visibility On-Demand Professional solution to analyze what it is spending and with whom, identify opportunities for savings.
Gary Bird, purchasing manager for Biomet, said, “In adopting and implementing Ariba Spend Visibility, we can gain a clear and centralized view into our spend that will allow us to streamline our supply base, enhance our sourcing process and ultimately, improve our cost structure.”
Spend Visibility provides analysis and control of spending across categories, systems, and divisions throughout an enterprise’s entire procure-to-pay cycle.
Biomet and its subsidiaries develop products used in both surgical and non-surgical therapy.